Global Chimeric Antigen Receptor T (CAR-T) Cells Market By Target Antigen (CD19, CD22, Others), Application (Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Others), End Use (Hospitals, Cancer Research Centres, Clinics), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027
Chimeric antigen receptor T (CAR-T) cells market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2324.90 million by 2027 growing at a CAGR of 49.20% in the above-mentioned forecast period. The growing awareness amongst the patients regarding the benefits of chimeric antigen receptor T (CAR-T) cells will uplift the growth of the market.